Atezolizumab in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials... von Mogollon-Duffo, F., Sultan, A., Swarup, S., Jahan, N., Tun, A.M., Win Htut, T., Naing, T.W., Naing, P.T., Mon Myat, Y., Hardwicke, F., Rehman, S., Tijani, L., D’Cunha, N., Thein, K.Z.

Volltext

1513P - Atezolizumab in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlle... von Mogollon-Duffo, F., Sultan, A., Swarup, S., Jahan, N., Tun, A.M., Win Htut, T., Naing, T.W., Naing, P.T., Mon Myat, Y., Hardwicke, F., Rehman, S., Tijani, L., D’Cunha, N., Thein, K.Z.

Volltext

Upfront atezolizumab chemoimmunotherapy-associated immune-related adverse events in patients with advanced non-small cell lung cancer von Mogollon-Duffo, F., Thein, K.Z., Tun, A.M., Swarup, S., Jahan, N., Adhikari, N., Htut, T Win, Naing, T.W., Hlaing, P.P., Myat, Y Mon, Naing, P.T., Hardwicke, F., Tijani, L., D’Cunha, N., Awasthi, S.

Volltext

1506P - Upfront atezolizumab chemoimmunotherapy-associated immune-related adverse events in patients with advanced non-small cell lung cancer von Mogollon-Duffo, F., Thein, K.Z., Tun, A.M., Swarup, S., Jahan, N., Adhikari, N., Htut, T Win, Naing, T.W., Hlaing, P.P., Myat, Y Mon, Naing, P.T., Hardwicke, F., Tijani, L., D’Cunha, N., Awasthi, S.

Volltext

A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer von Ott, P.A., Govindan, R., Naing, A., Friedlander, T.W., Margolin, K., Lin, J.J., Bhardwaj, N., Hellman, M.D., Srinivasan, L., Greshock, J., Moles, M., Gaynor, R.B., Goldstein, M.J., Hu-Lieskovan, S.

Volltext